Your browser doesn't support javascript.
Sickle cell disease: an update.
Conway O'Brien, Emma; Ali, Sahla; Chevassut, Timothy.
  • Conway O'Brien E; University Hospitals Sussex NHS Foundation Trust, Brighton, UK emma.conwayo'brien@nhs.net.
  • Ali S; University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
  • Chevassut T; University Hospitals Sussex NHS Foundation Trust, Brighton, UK and Brighton and Sussex Medical School, Falmer, UK.
Clin Med (Lond) ; 22(3): 218-220, 2022 05.
Article in English | MEDLINE | ID: covidwho-1903880
ABSTRACT
Sickle cell disease is a common inherited disorder that is characterised by chronic haemolysis and vaso-occlusive episodes, resulting in severe pain and end-organ damage. The most frequent acute manifestation of sickle cell disease is a painful vaso-occlusive crisis, which can, in some cases, develop into a sickle chest crisis a life-threatening complication of sickle cell disease that requires early recognition and prompt intervention to prevent progressive respiratory failure. In addition to the acute complications, patients with sickle cell disease are also at risk of a number of chronic complications that require multidisciplinary specialist input.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anemia, Sickle Cell Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Clin Med (Lond) Year: 2022 Document Type: Article Affiliation country: Clinmed.2022-0143

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Anemia, Sickle Cell Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Clin Med (Lond) Year: 2022 Document Type: Article Affiliation country: Clinmed.2022-0143